NCT04166903 (Pro-MagIC) is a clinical trial in Participants of the Be-MaGIC-Study 2009, sponsored by Technical University of Munich.

Who is sponsoring NCT04166903?

NCT04166903 is sponsored by Technical University of Munich.

What condition does NCT04166903 study?

NCT04166903 studies Participants of the Be-MaGIC-Study 2009.

Is NCT04166903 still recruiting?

NCT04166903 is currently completed. Last updated 17 September 2025.

Last reviewed 2025-09-17 · How we verify

NCT04166903: Pro-MagIC

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Prospective Follow-up, Marathon, Long Term, Inflammation and Cardiovascular System

Completed Last updated 17 September 2025

What this trial tests

trial in Participants of the Be-MaGIC-Study 2009 in 277 participants. Completed in 30 June 2021.

Timeline

15 November 2019

Primary endpoint
5 October 2020

30 June 2021

Quick facts

Lead sponsor	Technical University of Munich
Status	Completed
Study type	OBSERVATIONAL
Enrollment	277
Start date	15 November 2019
Primary completion	5 October 2020
Estimated completion	30 June 2021
Sites	1 location across Germany

Conditions studied

Participants of the Be-MaGIC-Study 2009 — all drugs for Participants of the Be-MaGIC-Study 2009 →

Sponsor

Technical University of Munich

Who can join

Adults 30 to 70, male only, with Participants of the Be-MaGIC-Study 2009. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

Pro-MagIC is a prospective observational study and includes participants of the Be-MaGIC-Study 2009 (n=277/NCT00933218). We aim to detect exercise-induced physiological changes (inter alia of the cardiovascular system) induced by repetitive ultra-endurance strain over a period of 10 years.

Publications & conference data

1 peer-reviewed publication reference this trial (live from Europe PMC):

Prospective long-term follow-up analysis of the cardiovascular system in marathon runners: study design of the Pro-MagIC study.
Schoenfeld J, Schindler MJ, Haller B, Holdenrieder S, et al · · 2020 · cited 6× · PMID 32704381 · DOI 10.1136/bmjsem-2020-000786

Verify or expand the search:

Other Technical University of Munich trials

Trials by the same sponsor.

NCT07519811 — LLM-Generated Plain-Language Patient Synopses to Improve Comprehension in Hematology and Oncology (oncOPAL) · NA · recruiting
NCT06650995 — AlEX-DHF: Ablation and Exercise in Diastolic Heart Failure · NA · recruiting
NCT07077005 — Mavacamten Enables Exercise in Hypertrophic Obstructive Cardiomyopathy · NA · recruiting
NCT07212699 — Development of an Outcome Score for Patients With Knee Osteoarthritis and Knee Joint Endoprosthesis Using an App · NA · recruiting
NCT06823271 — Haemodynamics and Ventricular Arrhythmias During Exercise in Patients With Arrhythmogenic Cardiomyopathy · NA · completed

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT04166903 (US National Library of Medicine, public domain)
Publications: Europe PMC API search by NCT ID, retrieved 9 June 2026
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Technical University of Munich
Last refreshed: 17 September 2025

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04166903.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing